Foundation News

Parsemus supports study of metformin to fight COVID-19

The Parsemus Foundation has provided seed funding to initiate research on use of the common diabetes medication metformin for prevention and treatment of COVID-19. The clinical study will be carried out by a team at the University of Minnesota led by co-principal investigators Carolyn Bramante, MD, MPH in the Department of Medicine and Christopher Tignanelli,… Read more

Stopping medical treatment as important as starting

Evidence-based medicine has focused on improving the chance of receiving the most appropriate medicine, treatments, and testing for each individual. Physicians from the University of Michigan advocate for more attention to the best time to stop medical treatments. In an article published in the Journal of the American Medical Association, Internal Medicine’s “Less is More”… Read more

Unraveling the link between diabetes and COVID-19

One of the risk factors for severe illness from COVID-19 is diabetes. While scientists aren’t sure why diabetes leads to poorer outcomes for COVID-19 patients, early studies indicate that controlling blood sugar may be an important component of treatment. Researchers from across the globe have been reporting that patients who have blood glucose monitoring and… Read more

Beware of these overused medical procedures

The overuse of certain medical procedures is a common problem in healthcare. The Journal of the American Medical Association, Internal Medicine produces an annual review of procedures, services, and tests that are often unnecessary, expensive, and may even cause harm to the patient. Here are the highlights from the 2018 and 2019 reports: Electrocardiograms are… Read more

Time to consider alternatives to surgical spay and neuter

The COVID-19 pandemic has impacted healthcare around the world — including veterinary care for pets. To reduce transmission and comply with shelter-in-place orders, many veterinary clinics are only open for emergencies. The American Veterinary Medical Association has asked veterinarians to defer elective procedures to preserve vital medical supplies for human use. Some veterinarians consider pet… Read more

Review of health implications of dog spay/neuter

Spaying and neutering can lead to long-term health problems in dogs. A recent review article summarizes these problems and illuminates the role of luteinizing hormone (LH). Ovaries and testes — the gonads — produce hormones such as estrogen and testosterone. Research has shown that removal of the gonads through spaying and neutering is associated with… Read more

Electromagnetic therapy effective for enlarged prostate

An inexpensive electromagnetic therapy quickly improved outcomes for men with enlarged prostates, according to a new study by researchers at Sapienza University of Rome with funding from the Parsemus Foundation. The results were published recently in Andrology, the highest ranked journal in andrological research. Benign prostatic hyperplasia (BPH), enlargement of the prostate, is a common… Read more

Spayed female dogs at higher risk of brain tumors

In a novel study using canine brain scans, scientists have reported that spayed females had an increased relative risk of brain tumors — 11 times that of intact females. The authors cited the importance of estrogen to brain health, and related their work in dogs to findings in women regarding higher incidence of dementia than… Read more

Parsemus Foundation recognized by journal

The Parsemus Foundation was awarded the 2019 Editor’s Choice Innovation Award in Complementary Medicine by the Innovative Veterinary Care Journal. This award recognizes the work that the foundation has done in the area of hormone-sparing dog sterilization. Our goal is to serve as an educational resource for pet owners and veterinarians about the research on… Read more

First treatment for hearing loss on the horizon

Thanks to a new patent for treating hearing loss using aldosterone and anti-inflammatory medication, humankind is a big step closer to reversing the #1 neurodegenerative disease of aging. If patent recipients Robert Frisina and colleagues at the University of South Florida successfully complete clinical trials, this method could be the first FDA-approved treatment for hearing… Read more